MEF cultures from p190-B RhoGAP mutant embryos
neither protein is detectably expressed ( Figure 1H ). Taken together, these results indicate that p190-B Rhoappear to be significantly impaired in their ability to undergo adipogenic conversion ( Figures 1C-1F ). Quan-GAP is required for the differentiation of adipocytes. tification of triglyceride production in cocktail-treated wild-type and mutant cells confirmed a reduction in fat production in mutant cells ( Figure 1G ). This analysis was Activation of the Rho GTPase Disrupts Adipogenesis by Blocking IGF-1 Signaling also performed on 3T3-L1 cells, a preadipocyte mouse cell line that undergoes adipogenesis with relatively high To identify the signaling pathway affected by the absence of p190-B RhoGAP, we first compared the ability efficiency and is used extensively in studies of adipogenic differentiation (Williams and Polakis, 1977 ) (Figure of wild-type and mutant MEFs to differentiate into adipocytes in differentiation medium lacking one or more of 1G). By this assay, the degree of adipogenesis detected in wild-type MEFs is comparable to that seen in 3T3-L1 the cocktail factors. As shown (Figure 2A ), IGF-1 appears to be the major factor that determines adipogenesis cells. To demonstrate that the reduced fat production in mutant cells reflects decreased adipogenic differentiin MEFs and is sufficient to induce some degree of adipogenesis in the absence of IBMX and dexamethaation as opposed to reduced fat metabolism, we examined the expression of the adipocyte markers PPAR␥ sone. Significantly, the same relative decrease in differentiation potential is observed in mutant MEFs treated and C/EBP␣. In wild-type MEFs exposed to the adipogenesis cocktail, expression of these markers is readily with only IGF-1 versus with the complete cocktail, indicating that the adipogenesis defect seen in cells lacking detected, whereas in MEFs lacking p190-B RhoGAP, 2C ). This result indicates that ROK is the Rho target that is relevant to defect in IGF-1 signaling in the mutant cells.
Our previous studies of MEFs lacking p190-B RhoGAP the inhibitory effects of Rho activation on adipogenesis and that the adipogenesis defect in cells lacking p190-B revealed that as expected, they contain increased levels of active Rho-GTP (Sordella et al., 2002) . Moreover, we RhoGAP is due to excessive Rho-ROK signaling in these cells. found that increasing Rho activity in wild-type cells is sufficient to impair IGF-1 signaling through a mechanism To verify that the adipogenesis defect in MEFs lacking p190-B RhoGAP reflects decreased signaling through involving an inhibitory phosphorylation on IRS by the Rho effector target, Rho-kinase (ROK). Therefore, we downstream components of the IGF-1 pathway, we examined the phosphorylation state of signaling proteins examined the ability of activated Rho to affect adipogenesis in cultured MEFs expressing the constitutively acpreviously implicated in the adipogenesis process, including IRS-1, p38␣, Akt1, and CREB, upon stimulation tive mutant RhoV14. As shown ( Figures 2B and 2C Figure 3A) . We confirmed that excessive Rho activity is sufficient to disrupt these signaling events downstream of IGF-1 by examining the phosphorylation of these signaling components in IGF-1-treated wild-type cells following infection with the RhoV14 adenovirus ( Figure 3A) . Moreover, pretreatment of the mutant cells with the ROK inhibitor, Y-27632, is sufficient to restore CREB and IRS phosphorylation to normal levels following IGF-1 treatment. We then determined that the effect of the ROK inhibitor on CREB phosphorylation is blocked by treatment with a p38MAPK inhibitor but that this agent does not affect IRS phosphorylation ( Figure 3A) . These results indicate that the effect of Rho and ROK on CREB phosphorylation is probably due to inhibition of signals downstream of the IGF-1 receptor that are mediated by p38␣ and CREB. Hence, it appears that the increased Rho activity in mutant MEFs prevents adipogenesis by inhibiting signaling downstream of IGF-1.
Rho Activity Is Downmodulated during IGF-Induced Adipogenesis via p190-B RhoGAP
The observation that excessive Rho signaling inhibits adipogenesis raised the possibility that Rho activity must normally be downmodulated during differentiation. Indeed, we found that levels of Rho-GTP are reduced considerably within 30 min of IGF-1 treatment, and they remain low over the course of several days ( Figure 3B ). Then, to address a potential role for p190-B RhoGAP in this process, we compared levels of Rho-GTP in wildtype and mutant MEFs following IGF-1 treatment. Whereas Rho-GTP levels are rapidly decreased by IGF-1 in wildtype cells (as seen in 3T3-L1 cells), Rho-GTP levels actually increase substantially in the mutant cells following IGF-1 treatment ( Figure 3C ). This result suggests that the active state of Rho following IGF-1 treatment reflects a balance between opposing activating and inhibitory Thus, the regulation of Rho GTPase activity appears to naling is sufficient to alter the differentiation outcome of precursors that have the capacity to become either be an important determinant of cell fate in the differentiation of adipocyte and myocyte precursors. adipocytes or myocytes.
Since p190-B RhoGAP is expressed in muscle cells, we hypothesized that it is regulated differently than it
The Role of Rho in Adipogenesis is in differentiating adipocytes. Indeed, we found that Previous studies revealed that modulation of Rho during myogenic differentiation of C2C12 cells, the tyroGTPase activity plays a role in the differentiation of sevsine phosphorylation of p190-B RhoGAP steadily deeral cell types, including neurons (Luo et al., 1996), T creases and parallels an increase in Rho-GTP levels lymphocytes (Henning et al., 1997), myocytes (Carnac (Figures 6E and 6F) Figure 6E) .
evidence that the inhibition of Rho GTPase activity is A provocative candidate for a tyrosine phosphatase necessary for the adipogenic differentiation program. that might dephosphorylate p190-B RhoGAP as a recipOur conclusion is based on the following observations. rocal regulatory event during myogenesis is SHP-2.
(
1) Newborn mice lacking the Rho inhibitory protein SHP-2 directly regulates components of the insulin sigp190-B RhoGAP exhibit a nearly complete absence of naling pathway (Maegawa et al., 1999), it localizes to mature adipocytes. (2) MEFs derived from p190-B Rholipid rafts (Lacalle et al., 2002), it promotes Rho activa-GAP-deficient animals are defective for adipogenesis, tion (Lacalle et al., 2002; O'Reilly et al., 2000), and it and the defect is rescued by a specific ROK inhibitor. can promote myogenic differentiation (Kontaridis et al., (3) Introduction of excessive Rho activity into wild-type 2001). During C2C12 differentiation, SHP-2 protein levMEFs or 3T3-L1 cells is sufficient to disrupt adipogenels steadily increase in parallel with an increase in Rhoesis. (4) Levels of active, GTP bound Rho are normally GTP levels (Figure 6F), and in coimmunoprecipitations, downregulated during the course of adipogenesis. we observed that SHP-2 physically associates with
Mechanistically, it appears that downmodulation of p190-B RhoGAP in a tyrosine phosphorylation-depenRho during adipogenesis results in relief from an inhibident manner ( Figure 6G ). Thus, SHP-2 is likely to play tory phosphorylation of IRS by the Rho effector target a role in the negative regulation of p190-B RhoGAP ROK and a consequent increase in IGF-1 signaling. We during muscle differentiation. Taken together, these rehave shown that activation of several downstream comsults suggest that the tyrosine phosphorylation status ponents of the insulin/IGF signaling pathway that are of p190-B RhoGAP provides a regulatory mechanism known to be required for adipogenesis is impaired when that determines levels of Rho activation in response to Rho activity is excessive and that adipogenesis is drainsulin/IGF signaling, thereby serving as a switch in an matically enhanced in the presence of the ROK inhibitor. adipogenesis-myogenesis "decision."
We also find that phosphorylation of the CREB transcription factor, which is sufficient to promote adipogenesis in 3T3-L1 cells, when activated ( In the context of the adipogenesis-myogenesis deciadipogenesis in vivo lead to the conclusion that down- 
Induction of Adipocyte Differentiation
3T3-L1 cells and MEFs were induced to differentiate as previously described (Miki et al., 2001) . Briefly, cells were propagated to confluence, and 2 days later, the medium was replaced with standard adipocyte differentiation induction medium containing 0.5 mM IBMX, 1 M dexamethasone, 5 g per ml insulin, 10% FBS, 50 U per ml penicillin, and 50 g per ml streptomycin (differentiation mixture; DMIX). Medium was replenished every second day for 7-10 days. 
